• American College of Medical Genetics. 2008. Standards and guidelines for clinical genetics laboratories.
  • Berg RS, Amendola LM, Eng C, Van Allen E, Gray SW, Wagle N, Rehm HL, DeChene ET, Dulik MC, Hisama FM, Burke W, Spinner NB, Garraway L, Green RC, Plon S, Evans JP, Jarvik GP, Members of the CSER Actionability and Return of Results Working Group. 2013. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Research Consortium. Genet Med 15:860867; PMID: 24195999.
  • Centers for Medicare & Medicaid Services. 2013. EHR incentive programs.
  • Centers for Medicare & Medicaid Services. Clinical Laboratory Improvement Amendments (Section 42 CFR §493. 1291).
  • Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD, Centers for Disease Control and Prevention (CDC). 2009. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep 58:137; PMID: 19521335.
  • Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, Bennett RL, Jones KL, Tokita MJ, Bennett JT, Kim JH, Rosenthal EA, Kim DS, National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project, Tabor HK, Bamshad MJ, Motulsky AG, Scott CR, Pritchard CC, Walsh T, Burke W, Raskind WH, Byers P, Hisama FM, Nickerson DA, Jarvik GP, 2013. Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet 93:110; PMID: 24055113.
  • Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565574.
  • Gulley ML, Braziel RM, Halling KC, Hsi ED, Kant JA, Nikiforova MN, Nowak JA, Ogino S, Oliveira A, Polesky HF, Silverman L, Tubbs RR, Van Deerlin VM, Vance GH, Versalovic J, Molecular Pathology Resource Committee, College of American Pathologists. 2007. Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med 131:852863; PMID: 17550311.
  • Lubin IM, McGovern MM, Gibson Z, Gross SJ, Lyon E, Pagon RA, Pratt VM, Rashid J, Shaw C, Stoddard L, Trotter TL, Williams MS, Amos Wilson J, Pass K. 2009. Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn 11:162171; PMID: 19197001.
  • Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE, Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. 2008. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 10:294300; PMID: 18414213.
  • Scheuner MT, Hilborne L, Brown J, Lubin IM, Members of the RAND Molecular Genetic Test Report Advisory Board. 2012. A report template for molecular genetic tests designed to improve communication between the clinician and laboratory. Genet Test Mol Biomarkers 16:761769; PMID: 22731646.
  • Scheuner MT, Edelen MO, Hilborne LH, Lubin IM, RAND Molecular Genetic Test Report Advisory Board. 2013. Effective communication of molecular genetic test results to primary care providers. Genet Med 15:444449; PMID: 23222660.
  • Tarczy-Hornoch P, Amendola L, Aronson SJ, Garraway L, Gray S, Grundmeier RW, Hindorff LA, Jarvik G, Karavite D, Lebo M, Plon SE, Van Allen E, Weck KE, White PS, Yang Y. A survey of informatics approaches to whole exome and whole genome clinical reporting in the electronic medical record. Genet Med 2013. 15:824832; PMID: 24071794.